CH652597A5 - Pharmazeutische komposition, enthaltend 1-(2-3'-carboxypropionyloxyaethyl)-2-methyl-5-nitroimidazol. - Google Patents

Pharmazeutische komposition, enthaltend 1-(2-3'-carboxypropionyloxyaethyl)-2-methyl-5-nitroimidazol. Download PDF

Info

Publication number
CH652597A5
CH652597A5 CH7680/81A CH768081A CH652597A5 CH 652597 A5 CH652597 A5 CH 652597A5 CH 7680/81 A CH7680/81 A CH 7680/81A CH 768081 A CH768081 A CH 768081A CH 652597 A5 CH652597 A5 CH 652597A5
Authority
CH
Switzerland
Prior art keywords
composition according
methyl
salts
nitroimidazole
administrable form
Prior art date
Application number
CH7680/81A
Other languages
German (de)
English (en)
Inventor
Jose Juan Morales Roman
Jose Antonio Martinez Venegas
Original Assignee
Silanes Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silanes Lab filed Critical Silanes Lab
Publication of CH652597A5 publication Critical patent/CH652597A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH7680/81A 1980-12-03 1981-12-01 Pharmazeutische komposition, enthaltend 1-(2-3'-carboxypropionyloxyaethyl)-2-methyl-5-nitroimidazol. CH652597A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX809191U MX6789E (es) 1980-12-03 1980-12-03 Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol

Publications (1)

Publication Number Publication Date
CH652597A5 true CH652597A5 (de) 1985-11-29

Family

ID=19741552

Family Applications (1)

Application Number Title Priority Date Filing Date
CH7680/81A CH652597A5 (de) 1980-12-03 1981-12-01 Pharmazeutische komposition, enthaltend 1-(2-3'-carboxypropionyloxyaethyl)-2-methyl-5-nitroimidazol.

Country Status (12)

Country Link
JP (1) JPS57188518A (nl)
BE (1) BE891284A (nl)
CA (1) CA1184120A (nl)
CH (1) CH652597A5 (nl)
DE (1) DE3147959A1 (nl)
FR (1) FR2494993A1 (nl)
GB (1) GB2089208A (nl)
IT (1) IT1145989B (nl)
LU (1) LU83802A1 (nl)
MX (1) MX6789E (nl)
NL (1) NL8105449A (nl)
PT (1) PT74056B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194283B (it) * 1983-06-21 1988-09-14 Isnardi Pietro & C Spa Derivato idrosolubile del 1-(2-idrossietil)-2-metil-5-nitro-imidazolo ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
AU9134791A (en) * 1990-12-11 1992-07-08 Brocades Pharma B.V. Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB983123A (en) * 1961-07-07 1965-02-10 Rhone Poulenc Sa Improvements in or relating to imidazole derivatives

Also Published As

Publication number Publication date
FR2494993A1 (fr) 1982-06-04
PT74056B (en) 1983-04-26
DE3147959A1 (de) 1983-03-24
CA1184120A (en) 1985-03-19
MX6789E (es) 1986-07-21
LU83802A1 (fr) 1983-09-01
GB2089208A (en) 1982-06-23
JPS57188518A (en) 1982-11-19
PT74056A (en) 1981-12-01
IT1145989B (it) 1986-11-12
NL8105449A (nl) 1982-07-01
IT8112688A0 (it) 1981-11-27
BE891284A (fr) 1982-06-01

Similar Documents

Publication Publication Date Title
EP0708640B1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
CH652597A5 (de) Pharmazeutische komposition, enthaltend 1-(2-3'-carboxypropionyloxyaethyl)-2-methyl-5-nitroimidazol.
DE69907387T2 (de) Verwendung von Hydantoin-Derivaten zur Herstellung eines Medikaments zur Behandlung von refraktärer Vasculitis.
DD201797A5 (de) Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE2713683A1 (de) Amidinopenicillanoyloxyalkylamoxycillinate, ihre herstellung und verwendung
DE2429756A1 (de) N-alkyl-0-(2-(2-alkyl-5-nitro-l-imidazolyl)-aethyl)-thiocarbamate, ihre salze, verfahren zu ihrer herstellung und arzneimittel
CH643814A5 (de) Hydroxamsaeureverbindungen, verfahren zu deren herstellung sowie diese verbindungen enthaltende medikamente.
DE3785953T2 (de) Bakterientötende Gemische.
DE2521922A1 (de) Pharmazeutisches mittel
DE3141970A1 (de) Arzneimittel zur behandlung der durch den virus der herpes-gruppe erzeugten erkrankungen
EP0152860B1 (de) Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems
EP1458389B1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion
DE3706431C2 (nl)
DD146459A5 (de) Verfahren zur herstellung von n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulphamoylbenzamid und seiner derivate
DE2462813C2 (de) Verwendung von acylierten Anilinobuttersäuren bzw. deren Salzen
DE1620177B2 (de) N-(2-Hydroxyäthyl) -piperazinocarboxymethyl-te tr acy elin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3037598C2 (de) Lysin- und Arginin-Salze der 5-(2,4-Difluorphenyl)-2-hydroxybenzoesäure, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2041831B2 (de) alpha Amino beta (N Benzylthio carbamoyl)-thiopropionsaure, Verfahren zu ihrer Herstellung sowie diese ent haltende Arzneimittel
DE2711223A1 (de) Thienamycinsulfoxid und thienamycinsulfon
DE3823345A1 (de) 6-merkaptopurin-derivate, ihre herstellung und ihre verwendung zur bekaempfung von retrovirusinfektionen
DE1792270C3 (de) Antirheumatikum enthaltend ein Magnesium- oder Calciumsalz eines Malonsäurehydrazid s
DE2221281B2 (de) Pharmazeutische Zubereitungen mit entzündungshemmender und analgetischer Wirkung

Legal Events

Date Code Title Description
PL Patent ceased